logo

LEXX

Lexaria Bioscience·NASDAQ
--
--(--)
--
--(--)

LEXX fundamentals

Lexaria Bioscience (LEXX) released its earnings on Jul 14, 2025: revenue was 174.00K (YoY --), beat estimates; EPS was -0.21 (YoY -61.54%), missed estimates.
Revenue / YoY
174.00K
--
EPS / YoY
-0.21
-61.54%
Report date
Jul 14, 2025

Earnings

EPS
Revenue

Revenue & Expenses

Key Indicators

Lexaria Bioscience (LEXX) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Lexaria Bioscience (LEXX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Lexaria Bioscience (LEXX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Lexaria Bioscience (LEXX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Lexaria Bioscience (LEXX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Lexaria Bioscience (LEXX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield